Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R McGuire

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Transplantation|September 1, 1988
Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocritG C Yee, T R McGuire, D J Gmur, et al.
The New England Journal of Medicine|July 14, 1988
Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantationG C Yee, S G Self, T R McGuire, et al.
The Annals of Pharmacotherapy|November 1, 1995
Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy menM S Shaefer, S J Rossi, T R McGuire, et al.
Transplantation|September 1, 1985
Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipientsM S Kennedy, G C Yee, T R Mcguire, et al.
Clinical & Experimental Metastasis|January 26, 2015
Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancerJ Wang, T R McGuire, H C Britton, et al.
Transplantation Proceedings|June 1, 1988
Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patientsT R McGuire, M S Tallman, G C Yee, et al.
Bone Marrow Transplantation|November 1, 1989
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 monthsG C Yee, T R McGuire, B A St Pierre, et al.
Bone Marrow Transplantation|January 10, 2002
Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrationsT R McGuire, G R Bociek, S Z Pavletic, et al.
Bone Marrow Transplantation|December 1, 1991
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapyW P Vaughan, J D Dennison, E C Reed, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Transplantation|September 1, 1988
Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocritG C Yee, T R McGuire, D J Gmur, et al.
The New England Journal of Medicine|July 14, 1988
Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantationG C Yee, S G Self, T R McGuire, et al.
The Annals of Pharmacotherapy|November 1, 1995
Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy menM S Shaefer, S J Rossi, T R McGuire, et al.
Transplantation|September 1, 1985
Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipientsM S Kennedy, G C Yee, T R Mcguire, et al.
Clinical & Experimental Metastasis|January 26, 2015
Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancerJ Wang, T R McGuire, H C Britton, et al.
Transplantation Proceedings|June 1, 1988
Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patientsT R McGuire, M S Tallman, G C Yee, et al.
Bone Marrow Transplantation|November 1, 1989
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 monthsG C Yee, T R McGuire, B A St Pierre, et al.
Bone Marrow Transplantation|January 10, 2002
Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrationsT R McGuire, G R Bociek, S Z Pavletic, et al.
Bone Marrow Transplantation|December 1, 1991
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapyW P Vaughan, J D Dennison, E C Reed, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Pageof 5